STACY EAGLE: Open Payments
NPI 1003513144 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,514 in 102 payments from 30 companies in 2025. Trend: 2023 $2,192 · 2024 $2,785 · 2025 $2,514
Food & beverage: $2,339Consulting: $175
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 8 | $210 |
| Alexion Pharmaceuticals, Inc. | 2 | $190 |
| Lilly USA, LLC | 5 | $181 |
| Lundbeck LLC | 9 | $177 |
| ABBVIE INC. | 10 | $168 |
| PFIZER INC. | 6 | $152 |
| Biogen, Inc. | 8 | $147 |
| ARGENX US, INC. | 5 | $135 |
| Neurelis, Inc. | 5 | $129 |
| Teva Pharmaceuticals USA, Inc. | 6 | $104 |
Products named: ULTOMIRIS, KISUNLA, NURTEC ODT, VYVGART HYTRULO, VALTOCO, VYEPTI, AUSTEDO XR, LEQEMBI.
Industry payments across GA — which companies pay providers there.
